James Samuel Shannon - Jun 13, 2024 Form 3 Insider Report for Xilio Therapeutics, Inc. (XLO)

Role
Director
Signature
/s/ Julia Walcott, Attorney-in-Fact
Stock symbol
XLO
Transactions as of
Jun 13, 2024
Transactions value $
$0
Form type
3
Date filed
6/17/2024, 04:11 PM
Previous filing
May 17, 2024

No securities are beneficially owned.

Remarks:

Exhibit 24 - Power of Attorney